Eurepa MF 1 Tablet

By Eurepa MF

Rx

10 Tablet in a Strip

Composition icon

Composition

Repaglinide(1mg) + Metformin(500mg)

Manufacturer - Torrent Pharmaceuticals Ltd icon

Manufacturer - Torrent Pharmaceuticals Ltd

Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after icon

Expires on or after

April, 2027

About Eurepa MF 1 Tablet

Eurepa MF 1 Tablet is a combination medication classified as an antidiabetic agent. It is specifically designed to help manage type 2 diabetes mellitus in adults. This condition affects how the body processes glucose, resulting in elevated blood sugar levels. Repaglinide and Metformin are the two active ingredients in Eurepa MF 1 Tablet. Repaglinide works by stimulating insulin production in the pancreas, especially after meals, while Metformin reduces glucose production by the liver, slows glucose absorption in the intestines, and enhances the body's response to insulin.

When taken as prescribed, Eurepa MF 1 Tablet helps prevent blood sugar spikes, thereby keeping diabetes under control. It is essential to follow a healthy lifestyle alongside medication, including weight management, regular exercise, and a balanced diet, as these factors greatly influence blood sugar levels. Remember to take Eurepa MF 1 Tablet with food to avoid stomach upset and at the same time each day for optimal results. Your doctor will determine the appropriate dosage based on your individual needs, which may require adjustments over time.

Despite its benefits, Eurepa MF 1 Tablet may cause low blood glucose levels, known as hypoglycemia, as a common side effect. Signs of hypoglycemia include dizziness, sweating, and hunger pangs. To mitigate this risk, it is crucial not to skip meals and have a quick-acting source of glucose on hand, such as sugary snacks or fruit juice. Other possible side effects of Eurepa MF 1 Tablet include changes in taste, nausea, diarrhea, stomach discomfort, headaches, and upper respiratory issues. If you experience any worsening side effects, consult your healthcare provider promptly.

Certain precautions must be observed while using Eurepa MF 1 Tablet. Do not take this medication if you have type 1 diabetes mellitus, severe kidney or liver disease, or are experiencing diabetic ketoacidosis. Patients with a history of heart disease should inform their doctor before starting Eurepa MF 1 Tablet. Pregnant or breastfeeding women should seek medical advice before taking this medication. Regular monitoring of blood sugar levels and potential blood tests may be necessary during treatment to assess your response and well-being. It is important to avoid alcohol consumption while on Eurepa MF 1 Tablet to minimize the risk of adverse effects.


Benefits

Eurepa MF 1 Tablet is a medication primarily used in the treatment of Type 2 diabetes mellitus. This tablet plays a crucial role in controlling high blood glucose levels by assisting in eliminating excess glucose from the body through urine. Moreover, it enhances the body's response to insulin, a hormone that regulates blood glucose levels. By improving insulin function, Repanide M helps in reducing blood glucose levels, particularly after meals, to prevent spikes. It is vital to adhere to the prescribed dosage regimen to reap the maximum benefits.

Managing and lowering blood glucose levels is paramount in the management of diabetes. By effectively controlling glucose levels with Repanide M, individuals can mitigate the risk of developing severe complications associated with diabetes, such as kidney damage, eye issues, nerve problems, and the possibility of limb loss. Consistently taking this medication in conjunction with a balanced diet and regular exercise routine assists individuals in leading a normal, healthy life. Embracing this holistic approach can significantly enhance overall well-being and improve long-term health outcomes for individuals with Type 2 diabetes mellitus.


How to use the Eurepa MF 1 Tablet

To use Eurepa MF 1 Tablet, you should follow the dosage and duration prescribed by your doctor. It is essential to swallow the tablet whole and not chew, crush, or break it. It is recommended to take Eurepa MF 1 Tablet with food. Following these instructions will help ensure the proper absorption of the medication in your body. Be sure to consult your doctor for specific guidance tailored to your individual needs and health condition.


Uses of Eurepa MF 1 Tablet

Eurepa MF 1 Tablet is primarily used for the treatment of Type 2 diabetes mellitus. It is specifically designed to help manage high blood sugar levels in individuals with this condition. By combining two key ingredients, this tablet can be effective in improving insulin sensitivity and controlling blood glucose levels. Patients with Type 2 diabetes mellitus can benefit from incorporating Eurepa MF 1 Tablet into their treatment regimen to help regulate their condition.


What conditions Eurepa MF 1 Tablet treats?

Eurepa MF 1 Tablet is used for the treatment of type 2 diabetes mellitus in adults. It helps control high blood sugar levels by improving the body's response to insulin. This medication is crucial in preventing complications such as kidney damage, eye damage, nerve problems, and loss of limbs associated with diabetes. It should be taken regularly with food as prescribed by your doctor to maintain stable blood sugar levels and avoid risks of severe health problems. Remember to follow a healthy lifestyle with diet and exercise as advised by your healthcare provider to effectively manage diabetes.


Should you consult a doctor?

If you experience low blood glucose levels (hypoglycemia) while taking Eurepa MF 1 Tablet, it is important to seek medical attention. Signs of hypoglycemia include sweating, dizziness, headache, and shaking. Knowing how to manage low blood sugar is crucial. Contact your doctor if side effects persist, especially if you have concerns. Additionally, consult a healthcare provider if you are worried about any potential adverse effects or experiencing symptoms such as diarrhea, loss of appetite, nausea, stomach pain, taste changes, or unexpected weight gain. It is recommended to monitor your blood sugar levels regularly and follow up with your doctor for necessary tests for blood cell counts and liver function. If you have any underlying conditions like type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart disease, always consult your doctor before taking Eurepa MF 1 Tablet. Pregnant or breastfeeding women should also seek medical advice before using this medication. Your healthcare provider will determine the appropriate dosage based on your individual needs and response to the treatment.


Side effects of Eurepa MF 1 Tablet

When taking Eurepa MF 1 Tablet, you may experience certain side effects. These side effects are typically temporary and may fade as your body gets used to the medication. However, if they persist or if you are concerned about them, it is important to consult your doctor.

Some common side effects of Eurepa MF 1 Tablet include hypoglycemia (low blood glucose level), sweating, dizziness, diarrhea, loss of appetite, nausea, stomach pain, taste change, and weight gain. It is essential to be aware of these potential side effects and to seek medical advice if needed.

If you notice any of these side effects while taking Eurepa MF 1 Tablet, consult your healthcare provider for guidance and appropriate management. It is important to prioritize your health and well-being while undergoing treatment with this medication.


Safety advice

scroll

liver

When using Eurepa MF 1 Tablet, caution should be taken in patients with liver disease. It may be necessary to adjust the dose of the medication, so it is important to consult your doctor before starting treatment. For patients with mild to moderate liver disease, Eurepa MF 1 Tablet is typically initiated at a low dose to ensure safety. However, the use of this medication is not advised for patients with severe liver disease. Make sure to discuss your liver condition with your healthcare provider before taking Eurepa MF 1 Tablet.

scroll

kidney

Eurepa MF 1 Tablet requires caution in patients with kidney disease. Dosage adjustment might be necessary, so consult your doctor. Avoid using Eurepa MF 1 Tablet in severe kidney disease. Regular kidney function tests are recommended during treatment.

scroll

alcohol

It is unsafe to drink alcohol while taking Eurepa MF 1 Tablet.

scroll

driving

If you experience symptoms of low or high blood sugar while using Eurepa MF 1 Tablet, avoid driving as it may affect your ability to drive safely.

scroll

pregnancy

Eurepa MF 1 Tablet should be used with caution during pregnancy. Limited human studies suggest potential harm to the baby based on animal studies. Your doctor will evaluate the benefits and risks before prescribing. Kindly consult your doctor.

scroll

breastfeeding

Eurepa MF 1 Tablet is likely safe during breastfeeding based on limited human data. The drug does not appear to pose a significant risk to the baby.


Consumption warning before consuming Eurepa MF 1 Tablet

Before consuming Eurepa MF 1 Tablet, it is important to note some key warnings. Always take this medication with food at the same time each day as prescribed by your doctor. Do not adjust the dosage without consulting your doctor, as it may affect how well it controls your blood sugar levels. Even if you feel well, continue taking the medication to prevent a rise in blood sugar levels, which could lead to severe complications like kidney damage, blindness, nerve problems, and limb loss. Remember, Repanide M is just one part of your diabetes treatment plan, which should include a healthy diet, exercise, and weight management.

The most common side effect of Repanide M is low blood glucose levels, so be aware of symptoms like sweating, dizziness, and headaches. Always carry a source of glucose to manage such situations. Avoid consuming alcohol, as it can further lower your blood sugar levels. Certain side effects such as taste changes, nausea, and weight gain may occur. Do not take this medication if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor about any heart conditions, pregnancy, or breastfeeding before starting Repanide M. Regular monitoring of blood sugar levels and necessary tests are essential for your well-being.


Related lab tests

Related Lab Tests for Eurepa MF 1 Tablet include tests to monitor blood glucose levels and assess overall diabetes management. These tests are essential for individuals taking Repanide M to ensure the medication is effectively controlling blood sugar levels. The Glucose - Fasting Blood test measures blood sugar levels after fasting for at least 8 hours, providing a baseline indicator of blood glucose control. The Glucose - Postprandial Blood test is done 2 hours after a meal to assess how the body processes glucose after eating. Lastly, the Glycosylated Hemoglobin test, also known as the HbA1c test, provides a long-term measurement of blood sugar levels over the past 2-3 months. These lab tests play a crucial role in managing diabetes and evaluating the effectiveness of Repanide M in controlling blood sugar levels.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

196.78

231.5

15% OFF

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 11-Feb-2025